[1] ZHANG Y, XU F, LYU XJ.Literature analysis of 44 cases of adverse reactions/events of voriconazole[J]. West China Medical Journal(华西医学), 2016, 31(11): 1850-1853. [2] XU YB, FANG HH, XIA Q, et al.A retrospective analysis of 64 cases of adverse reactions of voriconazole[J]. Chinese Journal of New Drugs(中国新药杂志), 2019, 28(13): 1661-1664. [3] XI LY, LU H, SHI QZ, et al.Analysis of adverse reactions of voriconazole for injection in China[J]. Chinese Pharmacist(中国药师), 2020, 23(1): 116-119. [4] CHENG L, WENG BB, XIANG RF, et al.Hypokalemia and hyponatremia induced by voriconazole and their relationship with valley concentration of voriconazole[J]. Journal of the Third Military Medical University(第三军医大学学报), 2020, 42(13): 1350-1354. [5] CHENG L, XIANG RF, LIU F, et al.Therapeutic drug monitoring and safety of voriconazole in elderly patients[J]. Int Immunopharmacol, 2020(78): e106078. [6] BENITEZ LL, CARVER PL.Adverse effects associated with long-term administration of azole antifungal agents[J]. Drugs, 2019, 79(8): 833-853. [7] TANG JX, HU QZ, XU X.Risk factors of common clinical adverse reactions of voriconazole[J]. Chinese Journal of clinical Pharmacy(中国临床药学杂志), 2020, 29(6): 469-473. [8] GU BX, WU JB, SHEN J, et al.Analysis of risk factors of hypokalemia in elderly patients with respiratory infection associated with moxifloxacin injection[J]. Chinese Journal of Infection and Chemotherapy(中国感染与化疗杂志), 2020, 20(5): 502-505. [9] National Center for Adverse Drug Reactions, Center for Drug Evaluation, State Food and Drug Administration. WHO terminology of adverse drug reactions(WHO药品不良反应术语集)[M]. Beijing: China Medical Science and Technology Press, 2002: 1-172. [10] WU H, ZHENG R.Research progress of voriconazole trough concentration in guiding population clinical medication[J]. International Journal of Pharmaceutical Research(国际药学研究杂志), 2018, 45(3): 182-186. [11] GUO Z, LIU XY, CHEN LN, et al.Clinical efficacy of voriconazole injection in the treatment of invasive pulmonary fungal infection after chemotherapy of blood tumor[J]. Journal of Modern Oncology(现代肿瘤医学), 2020, 28(21): 3786-3789. [12] YANG LN, JIANG LL, LI RB.Cause analysis and countermeasures of hypokalemia in elderly patients with coronary heart disease[J]. Chinese Journal of Heart and Rhythm(中华心脏与心律电子杂志), 2018, 4(1): 46-47. [13] LIU XS, HE WQ, CHEN WY, et al.Clinical application of voriconazole concentration monitoring in patients with pulmonary fungal infection[J]. National Respiratory Journal(国家呼吸杂志), 2016, 36(20): 1521-1526. [14] WU LL, JIANG JY, WANG HH, et al.Efficacy and safety of voriconazole in the treatment of hematological diseases complicated with invasive fungal diseases[J]. Anhui Medical Journal(安徽医学), 2019, 40(6): 664-667. [15] MATTHAIOU DK, DIMOPOULOS G, TACCONE FS, et al.Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort[J]. Med Mycol, 2018, 56(6): 668-678. [16] LIANG SY.Sepsis and other infectious disease emergencies in the elderly[J]. Emerg Med Clin North Am, 2016, 34(3): 501-522. [17] SHI JX.The significance of rapid diagnosis of hypokalemia by electrocardiograph in emergency department[J]. Rational Clinical Use, 2016, 9(7): 176-178. |